⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PSTV News
PLUS THERAPEUTICS, Inc. Common Stock
Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives
globenewswire.com
PSTV
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PSTV
Plus Therapeutics Announces Reverse Stock Split
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors
globenewswire.com
PSTV
Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Form 8-K
sec.gov
PSTV